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Abstract
Background: Intraoperative mechanical ventilation may influence postoperative pulmonary complications (PPCs).
Current practice during thoracic surgery is not well described.
Methods: This is a post-hoc analysis of the prospective multicenter cross-sectional LAS VEGAS study focusing on
patients who underwent thoracic surgery. Consecutive adult patients receiving invasive ventilation during general
anesthesia were included in a one-week period in 2013. Baseline characteristics, intraoperative and postoperative
data were registered. PPCs were collected as composite endpoint until the 5th postoperative day. Patients were
stratified into groups based on the use of one lung ventilation (OLV) or two lung ventilation (TLV), endoscopic vs.
non-endoscopic approach and ARISCAT score risk for PPCs. Differences between subgroups were compared using
χ2 or Fisher exact tests or Student’s t-test. Kaplan–Meier estimates of the cumulative probability of development of
PPC and hospital discharge were performed. Cox-proportional hazard models without adjustment for covariates
were used to assess the effect of the subgroups on outcome.
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Results: From 10,520 patients enrolled in the LAS VEGAS study, 302 patients underwent thoracic procedures and
were analyzed. There were no differences in patient characteristics between OLV vs. TLV, or endoscopic vs. open
surgery. Patients received VT of 7.4 ± 1.6 mL/kg, a PEEP of 3.5 ± 2.4 cmH2O, and driving pressure of 14.4 ± 4.6
cmH2O. Compared with TLV, patients receiving OLV had lower VT and higher peak, plateau and driving pressures,
higher PEEP and respiratory rate, and received more recruitment maneuvers. There was no difference in the
incidence of PPCs in OLV vs. TLV or in endoscopic vs. open procedures. Patients at high risk had a higher incidence
of PPCs compared with patients at low risk (48.1% vs. 28.9%; hazard ratio, 1.95; 95% CI 1.05–3.61; p = 0.033). There
was no difference in the incidence of severe PPCs. The in-hospital length of stay (LOS) was longer in patients who
developed PPCs. Patients undergoing OLV, endoscopic procedures and at low risk for PPC had shorter LOS.
Conclusion: PPCs occurred frequently and prolonged hospital LOS following thoracic surgery. Proportionally large
tidal volumes and high driving pressure were commonly used in this sub-population. However, large RCTs are
needed to confirm these findings.
Trial registration: This trial was prospectively registered at the Clinical Trial Register (www.clinicaltrials.gov; NCT016
01223; registered May 17, 2012.)
Keywords: Thoracic surgery, Mechanical ventilation, General anesthesia, Perioperative complications
Background
Approximately 234 million major surgical procedures
are undertaken worldwide every year [1]. Among these,
approximately 7 million patients develop major compli-
cations resulting in one million deaths during surgery or
in-hospital stay, contributing to an estimated mortality
rate after anesthesia of 34 per million [1, 2]. According
to the ‘Local assessment of ventilatory management dur-
ing general anesthesia for surgery and effects on postop-
erative pulmonary complications’ (LAS VEGAS) trial,
postoperative pulmonary complications (PPC) occur in a
significant proportion of surgical patients [3]. However,
since thoracic surgery requires a differentiated ventila-
tory approach, those patients were excluded from the
primary analysis of the LAS VEGAS study. In thoracic
surgery, conventional methods to prevent and treat hyp-
oxemia during one lung ventilation (OLV) can be harm-
ful to the lung tissue: high fraction of inspired oxygen
(FIO2) and low (or no) positive end–expiratory pressure
(PEEP) both can promote atelectasis, whereas high tidal
volume (VT) can cause baro- and volutrauma [4]. The
type of thoracic surgery (open or endoscopic) as well as
the intraoperative mechanical ventilation settings may
also influence PPCs.
Intraoperative mechanical ventilation with low VT, low
driving pressure, and low to moderate PEEP improved
postoperative lung function and even outcome in pa-
tients undergoing open abdominal surgery [5, 6]. When
low VT was used in abdominal surgery, high PEEP com-
bined with recruitment maneuvers, as compared to low
PEEP without recruitment maneuvers, did not add to
the protection against PPCs [7].
The present study aimed to characterize the current
mechanical ventilation practice during general anesthesia
for thoracic surgery, describe the incidence of PPCs, and
investigate possible associations between type of surgery
(open vs. endoscopic), type of ventilation (OLV or two
lung ventilation) and risk for PPCs (low risk vs high)
with the incidence of PPCs. We hypothesized that intra-
operative mechanical ventilation, as recommended in
the literature, namely with low VT, low driving pressure,
and low to moderate PEEP [8], is not commonly used
during thoracic surgery, and that the incidence of PPCs
is higher in this surgical population than in non-thoracic
surgery.
Methods
Study design and sites
The present work is a post hoc analysis of the ‘Local as-
sessment of ventilatory management during general
anesthesia for surgery and effects on postoperative pul-
monary complications’ (LAS VEGAS trial) [3]. The LAS
VEGAS trial protocol was first approved by the institu-
tional review board of the Academic Medical Center,
Amsterdam, The Netherlands (W12_190#12.17.0227)
and registered at clinicaltrials.gov (NCT01601223). The
protocol of this trial was published elsewhere [9].
Study population and data collection
Consecutive adult patients receiving invasive ventilation
during general anesthesia for elective or non–elective
surgery were eligible for participation in the study, which
ran for seven predefined days in each country, selected
by the national coordinator, in the period between
January 14th and March 4th, 2013. Patients were ex-
cluded from participation if they were aged < 18 years, or
scheduled for pregnancy related surgery, surgical proce-
dures outside the operating room, or procedures involv-
ing cardio-pulmonary bypass.
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The patient database of the LAS VEGAS trial was
searched for eligible patients who received either open
thoracic surgery, thoracoscopic or thoracoscopy assisted
surgery (both summarized as endoscopic surgery), with
or without OLV. These data have not been considered
in previous analyses.
Reasonable parameters of baseline characteristics, in-
traoperative data and preoperative risk factors for PPCs
were identified from previous studies [10–13]. During
the intraoperative period, data describing ventilation set-
tings and vital parameters, as well as episodes of hypoxia
(SpO2 < 92%), use of recruitment maneuvers, airway
pressure reduction, presence of expiratory flow limita-
tion, hypotension (mean arterial pressure < 60mmHg),
use of vasoactive drugs, and new arrhythmias, was
collected. Postoperative residual curarisation with neuro-
muscular blocking agents (NMBAs), defined as train–
of–four stimulation (TOF) ratio < 0.9, was documented.
The definition of protective mechanical ventilation is
still under debate. For this analysis it was based on re-
cent recommendations [8, 14–16]. Patients were consid-
ered to be have been protectively ventilated “as
recommended” if PEEP ≥5 cmH2O and VT ≤ 8 ml/kg
PBW during TLV [8, 14, 17], and PEEP ≥5 cmH2O and
VT ≤ 5 ml/kg PBW during OLV [18–20].
The occurrence of PPCs is presented as a collapsed
composite of PPCs in the first five postoperative days.
The following PPCs were scored daily from the day of
surgery until hospital discharge or postoperative day 5:
1) need for supplementary oxygen (due to PaO2 < 60
mmHg or SpO2 < 90% in room air, excluding oxygen
supplementation given as standard care or as continu-
ation of preoperative therapy), 2) respiratory failure
(PaO2 < 60 mmHg or SpO2 < 90% despite oxygen ther-
apy, or need for non-invasive mechanical ventilation), 3)
unplanned new or prolonged invasive or non–invasive
mechanical ventilation, 4) acute respiratory distress syn-
drome, 5) pneumonia. Severe PPCs were defined as the
occurrence of one or more of the complications 2–5. Pa-
tient data were anonymized before entry onto a pass-
word secured, web–based electronic case record form
(OpenClinica, Boston, MA, USA).
Statistical analysis
Patients were stratified into groups based on: 1) use or
not of OLV (OLV vs. only TLV); 2) use or not of an
endoscopic approach (endoscopic vs. open); and 3) risk
for PPC according to ARISCAT (low risk [ARISCAT <
26] vs. moderate-to-high risk [ARISCAT ≥26] Supple-
mental Table 2, Additional file 1). The ventilatory data,
which were collected hourly, were first averaged for each
patient according to the number of observations (median
of the value). In a longitudinal analysis, this data is pre-
sented for the first, second, third, fourth and last hour of
surgery. All data are presented for the whole population
and for the subgroups. In-hospital length of stay (LOS)
and in-hospital mortality was censored at postoperative
day 28. Proportions are compared using χ2 or Fisher
exact tests and continuous variables are compared using
the Mann-Whitney U Test, as appropriate.
The distributions of combinations of tidal volume size
and PEEP level are presented in scatter plots. Cut-offs of
6 ml/kg PBW for tidal volume, and 5 cmH2O for PEEP
were chosen to form the matrices. These cut-offs were
based on widely accepted values of each variable, or ac-
cording to normal daily practice. The driving pressure
was defined as plateau pressure (Pplat) minus the PEEP
level.
Kaplan–Meier estimates of the cumulative probability
of development of PPC and hospital discharge were per-
formed. Cox proportional hazard models without adjust-
ment for covariates were used to assess the effect of the
subgroups on outcome. The proportionality assumption
was tested with scaled Schoenfeld residuals. Adjustments
for multiple comparisons were not performed and no as-
sumption for missing data was done. Statistical signifi-
cance was considered to be at two-sided p < 0.05. All
analyses were performed with R version 3.4.1 (http://
www.R-project.org/).
Results
From 10,520 patients enrolled in the LAS VEGAS study,
302 patients underwent thoracic procedures (Supple-
mental Figure 1, Additional file 1). Characteristics of
patient and surgery are shown in Table 1. In this sub-
population of 302 thoracic surgical patients, 55% (168/
302) received OLV, 15.2% (46/302) were operated with
an endoscopic approach and 87.4% (264/302) had
moderate-to-high risk for PPCs.
Characteristics of patients undergoing procedures with
OLV vs. TLV, and endoscopic vs. open were compar-
able. Patients with moderate-to-high risk for PPCs were
different from those at low risk with respect to age, gen-
der, BMI, ASA status, COPD prevalence and planned
duration of surgery (Table 1).
Intra-operative characteristics
Patients operated under OLV received more often
double-lumen tubes and had more frequently lung
or pleural surgery than those operated under TLV
(Table 1). Use of epidural anesthesia was less and
duration of surgery shorter in endoscopic compared
to non-endoscopic surgery (Table 1).
Patients at moderate-to-high risk for PPC received
more frequently antibiotic prophylaxis and epidural
anesthesia, and had longer duration of surgery as well as
anesthesia, compared with patients at low risk (Table 1).
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The amounts of crystalloids, colloids, albumin and
packed red blood cells was higher in open vs. endoscopic
surgery, and in patients at moderate-to-high vs. low risk
for PPC (Table 2).
Mechanical ventilation
Patients were ventilated with VT of 7.4 ± 1.6 ml/kg PBW,
PEEP of 3.5 ± 2.4 cmH2O, and driving pressure of 14.4 ±
4.6 cmH2O (Table 2). Compared to patients operated
solely under TLV, patients receiving OLV had lower VT,
higher peak, plateau and driving pressures, as well as
PEEP and respiratory rate, and received higher number
of recruitment maneuvers (Table 2). Protective ventila-
tion was used in 14.8% (41/302) of all patients, mainly
during TLV. The ventilatory management of patients
undergoing endoscopic and non-endoscopic procedures
did not differ significantly. Patients at moderate-to-high
risk for PPC had higher levels of PEEP, and received
more recruitment maneuvers than patients at low risk
(Table 2).
Values of ventilator settings along time are shown in
Supplemental Figures 2 through 4 (Additional file 1). Pa-
tients operated under OLV had higher FiO2 compared
with patients operated under TLV (Supplemental Figure
2, Additional file 1). The combinations of VT and PEEP
according to subgroups are shown in Supplemental Fig-
ures 5 through 7 (Additional file 1).
Primary outcome
The overall incidence of PPCs in this population was
45.7% (138/302), and did not differ significantly
between OLV vs. TLV (82/168 vs. 56/134, 48.8% vs.
41.8%, p = 0.223, total number and percentage re-
spectively), and endoscopic vs. open procedures (16/
46 vs. 122/256, 34.8% vs. 47.7%, p = 0.106, total num-
ber and percentage respectively, Table 3, Fig. 1).
Patients at moderate-to-high risk showed an increased
incidence of PPC compared to patients at lower risk
(48.1% vs. 28.9%; hazard ratio, 1.95; 95% CI 1.05–
3.61; p = 0.033), mainly due to unplanned need for
supplemental oxygen (Table 3, Fig. 1).
Secondary outcomes
The incidence of severe PPCs, unplanned ICU admission
and hospital mortality did not differ among groups
(Table 3). The incidence of hypotension was decreased
in endoscopic compared to open procedures, and in pa-
tients at lower compared to moderate-to-high risk of
PPCs (Table 3).
The LOS was increased in patients who developed
PPCs (Supplemental Figure 8, Additional file 1), and
shorter in patients operated under OLV vs. TLV, endo-
scopic vs. open, and those with low vs. moderate-to-high
risk for PPC (Table 3, Fig. 2).
Discussion
In this population of patients undergoing thoracic sur-
gery: 1) mechanical ventilation differed from those rec-
ommended for lung protection in 85.2% of all patients;
2) patients under OLV received lower VT, higher peak,
plateau and driving pressures, higher PEEP levels and re-
spiratory rate, and received more recruitment maneuvers
compared with TLV; 3) the overall incidence of PPCs
was as high as 45.7%; 4) PPCs were more common
among patients with higher ARISCAT score or co-
morbidities, but not increased following open vs.
endoscopic procedures, or OLV vs. TLV; 6) PPCs were
associated with increased LOS.
To our knowledge, this is the first prospective observa-
tional investigation addressing the practice of mechan-
ical ventilation and incidence of PPCs in thoracic
anesthesia. The main strengths of our study are that data
was stored, analyzed and reported according to inter-
national standards [21].
High VT strategies, usually accompanied by low or
zero PEEP, have been used to prevent intraoperative
atelectasis [22, 23]. However, this may cause overdisten-
sion (volutrauma), and repetitive collapse-reopening of
lung units (atelectrauma), which can injure the lungs
and lead to PPCs [24]. A protective ventilation approach
consisting mainly of low VT reduces the incidence of
PPCs [7, 25]. This seems to apply also to thoracic
anesthesia but this claim is not undisputed [26–28]. The
present study shows that protective mechanical ventila-
tion, as recommended, was used in less than 15% of pa-
tients undergoing thoracic surgery. Different possible
reasons might explain this finding: 1) the concept of
protective ventilation during surgery is still not wide-
spread among anesthesiologists; 2) the role of single
components of mechanical ventilation in lung protec-
tion, especially of PEEP, is still poorly defined, leading
anesthesiologists to set values according to their own
preferences; 3) sound evidence from large RCTs demon-
strating the benefit of protective mechanical ventilation
in thoracic surgical patients is still missing; 4) thoracic
surgical procedures usually last less than 1 hour, which
might be deemed as too short to benefit from protective
mechanical ventilation; 5) mechanical ventilation set-
tings guided by driving pressure may result in VT and
PEEP outside the range that has been recommended for
protective mechanical ventilation.
The incidence of PPCs after surgery is influenced by
patient-related factors, and type of surgery. In a mixed
surgical population without surgery involving cardiopul-
monary bypass, 10.4% of patients developed PPCs within
the first postoperative 5 days; values ranged from 6.7% in
plastic/cutaneous procedures to 38.2% in transplant sur-
gery [3]. In open abdominal surgery, PPCs were reported
in 10.5 to 39.0% of patients, despite the use of a
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protective ventilation strategy [3, 7, 25]. In average,
10.7% of patients at increased risk, for example obese
patients, developed PPCs [29]. In patients undergoing
thoracic surgery, an incidence of PPCs between 10.7 and
50% has been reported [26, 30–32]. This relatively wide
range is possibly explained by differences in definition of
pulmonary complications among trials. The rate of se-
vere PPCs was 17.5% in our thoracic surgery population,
which is comparable to the rate of 18.1% reported by
Blank and colleagues [26].
The observation that patients who developed PPCs
had more comorbidities and longer LOS is in line with
previous studies addressing intraoperative TLV [3, 33].
The difference in LOS in the subgroups is likely ex-
plained by the type of procedure per se, where open ap-
proaches require a prolonged treatment due to more
complex procedures, independent from the type of
mechanical ventilation.
Although the incidence of PPCs was relatively high, nei-
ther open thoracic surgery procedures, nor OLV itself
were associated with them, especially when taking the in-
frequent use of protective mechanical ventilation in this
population into account. The precise role of PEEP for pro-
tective intraoperative mechanical ventilation has been
challenged in recent trials [7, 34]. In fact, it has been sug-
gested that a strategy aimed at permissive atelectasis might
be as protective as a strategy to open lungs during surgery
[14, 35]. Our finding that higher VT was not associated
with PPCs is intriguingly, but in agreement with data from
an observational study reporting that the use of VT as high
as 8mL/kg as even associated with better pulmonary out-
come [26]. Together, these findings suggest that protective
OLV settings are more complex than previously thought.
Cutoff values, although valuable, must not only consider
the interaction among variables, but also a possible role of
airway pressures.
Limitations
This study has several limitations. First, a one-week in-
clusion period was relatively short in order to include a
Table 3 Clinical Outcomes of the Patients According to Subgroups
All Patients
(n = 302)
OLV
(n = 168)
TLV
(n = 134)
p value Endoscopic
(n = 46)
Open
(n = 256)
p value Low Risk
(n = 38)
High Risk
(n = 264)
p value
Primary outcome
PPC 138 (45.7) 82 (48.8) 56 (41.8) 0.223 16 (34.8) 122 (47.7) 0.106 11 (28.9) 127 (48.1) 0.026
Need of oxygen 109 (36.1) 65 (38.9) 44 (32.8) 0.274 12 (26.1) 97 (38.0) 0.120 8 (21.1) 101 (38.4) 0.037
Respiratory failure 26 (8.6) 15 (8.9) 11 (8.2) 0.824 1 (2.2) 25 (9.8) 0.148 2 (5.3) 24 (9.1) 0.755
Invasive MV 26 (8.6) 14 (8.3) 12 (9.0) 0.848 3 (6.5) 23 (9.0) 0.778 1 (2.6) 25 (9.5) 0.222
NIV 15 (5.0) 10 (6.0) 5 (3.7) 0.377 2 (4.3) 13 (5.1) 1.000 1 (2.6) 14 (5.3) 0.702
ARDS 4 (1.3) 4 (2.4) 0 (0.0) 0.132 0 (0.0) 4 (1.6) 1.000 0 (0.0) 4 (1.5) 1.000
Pneumonia 8 (2.6) 6 (3.6) 2 (1.5) 0.307 2 (4.3) 6 (2.3) 0.350 1 (2.6) 7 (2.7) 1.000
Secondary outcomes
Severe PPCa 53 (17.5) 30 (17.9) 23 (17.2) 0.875 7 (15.2) 46 (18.0) 0.651 4 (10.5) 49 (18.6) 0.223
Intra-OP complications
Desaturation 61 (20.2) 38 (22.6) 23 (17.2) 0.240 7 (15.2) 54 (21.1) 0.360 5 (13.2) 56 (21.2) 0.247
Unplanned RM 48 (15.9) 31 (18.5) 17 (12.7) 0.173 7 (15.2) 41 (16.0) 0.891 3 (7.9) 45 (17.0) 0.149
Pressure reduction 36 (11.9) 27 (16.1) 9 (6.7) 0.012 5 (10.9) 31 (12.1) 0.811 2 (5.3) 34 (12.9) 0.281
Flow limitation 3 (1.0) 2 (1.2) 1 (0.8) 1.000 0 (0.0) 3 (1.2) 1.000 0 (0.0) 3 (1.1) 1.000
Hypotension 102 (33.8) 60 (35.7) 42 (31.3) 0.424 8 (17.4) 94 (36.7) 0.010 3 (7.9) 99 (37.5) < 0.001
Vasopressors 113 (37.4) 65 (38.7) 48 (35.8) 0.608 13 (28.3) 100 (39.1) 0.163 3 (7.9) 110 (41.7) < 0.001
New arrhythmias 6 (2.0) 3 (1.8) 3 (2.2) 1.000 0 (0.0) 6 (2.3) 0.595 0 (0.0) 6 (2.3) 1.000
ICU admissionb 6 (2.0) 2 (1.2) 4 (3.0) 0.411 0 (0.0) 6 (2.3) 0.595 0 (0.0) 6 (2.3) 1.000
Hospital LOS, days 6.0 (3.0–10.0) 6.0 (4.0–11.0) 5.0 (3.0–9.0) 0.010c 3.0 (1.0–7.5) 6.0 (4.0–10.0) < 0.001c 4.0 (1.0–6.0) 6.0 (4.0–10.0) < 0.001c
Hospital mortality 1 (0.3) 1 (0.6) 0 (0.0) 1.000 0 (0.0) 1 (0.4) 1.000 0 (0.0) 1 (0.4) 1.000
Values are presented as median (interquartile range) or number (percentage). p values from a Proportions χ2 or Fisher exact tests for proportions and Mann-
Whitney U Test for continuous variables ARDS Acute respiratory distress syndrome, ICU Intensive care unit, Intra-OP Intraoperative, LOS Length of stay, MV
Mechanical ventilation, NIV Non-invasive ventilation, OLV One lung ventilation, PPC Postoperative pulmonary complication, RM Recruitment maneuvers, TLV Total
lung ventilation
aexcluding need of oxygen
bunplanned admission
cp value from the Cox proportional hazard model
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high number of patients per center. However, this fact
was counterbalanced by the multicenter design. Second,
a short inclusion period might have resulted in selection
bias, since fluctuation of the severity of cases cannot be
ruled out. Nevertheless, the benefits of avoiding changes
in therapy during the observation period as a potential
confounder should not be underestimated. Third, the
definition of protective mechanical ventilation was based
on recommendations that are still under debate. Fourth,
most study sites included less than 10 patients. This
number, however, does not imply lack of experience
with the procedure, since thoracic anesthesia per se
already requires a substantial degree of expertise. Fifth,
the duration of OLV was not investigated and, therefore,
the exact contribution of OLV to PPCs cannot be sepa-
rated from the period under TLV in this sub-population.
Sixth, the design of this study precludes the possibility of
determining cause-effect relationships, and results must
be seen from a hypothesis-generating perspective. Sev-
enth, the fact that data was collected prospectively might
have interfered with clinical practice itself, and biased
towards the use of protective ventilation. Still, non-
protective ventilation was used in a vast majority of pa-
tients. Eighth, the total number of patients enrolled
allowed analyses of three subgroups only. Potential con-
founders could be the type of anesthesia (total intraven-
ous anesthesia vs. volatile anesthetics), the type of
postoperative analgesia (epidural anesthesia vs. opioids)
or the ASA status, which should be subject of future
trials.
Conclusions
The present study provides relevant insight into the
practice of mechanical ventilation during thoracic sur-
gery. The data might prove useful for the development
of scores for risk prediction in this particular population,
allocation of human and financial resources, including
need for postoperative monitoring in dedicated units,
and also estimation of sample size in interventional trials
[18]. Mechanical ventilation practice did not follow
Fig. 1 Probability of PPC according to the subgroups assessed. PPC: postoperative pulmonary complications; OLV: one-lung ventilation; TLV:
two-lung ventilationNon-adjusted hazard ratios.
Fig. 2 Probability of hospital discharge according to the subgroups assessed. OLV: one-lung ventilation; TLV: two-lung ventilation. Non-adjusted
hazard ratios
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current recommendations for lung protection in the vast
majority of patients undergoing thoracic surgery. Al-
though PPCs were common in this population, and asso-
ciated with increased LOS, their incidence was not
higher following open vs. endoscopic or OLV vs. TLV,
and not associated with mechanical ventilation settings.
It must be emphasized that the lack of association be-
tween mechanical ventilation settings and PPCs does not
support use of non-protective VT and PEEP in this
population.
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